Lead sponsor
PRAECIS Pharmaceuticals Inc.
2 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
2
Trials led
0
Ongoing
149
Total enrollment
3
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
1
Phase 1/2
1
Trials by status
Completed
2
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Safety Study of PPI-1019 in Patients With Mild-Moderate Alzheimer's DiseaseAlzheimer's diseasePh 1Completed125
Safety Study of PPI-1019 in Subjects With Mild-Moderate Alzheimer's DiseaseAlzheimer's diseasePh 1/2Completed24